By now, you've probably heard about the recall of a popular heartburn medication. Some drugs that contain ranitidine (best known as Zantac) have been found by the FDA to have unacceptable amounts of N-nitrosodimethylamine (NDMA), a possible cancer-causing chemical (which also triggered recalls of certain lots of the blood pressure drugs called angiotensin-receptor blockers). While the FDA investigates ranitidine, you're advised to talk to your doctor about whether to keep taking it. One alternative: switching to a similar drug, such as over-the-counter famotidine (Pepcid) or cimetidine (Tagamet). They're all in a class of medications known as H2 blockers, which block a chemical that signals the stomach to produce acid. "They're fairly interchangeable, working equally well for most people," says Dr. Kyle Staller, a gastroenterologist with Harvard-affiliated Massachusetts General Hospital.
Stronger heartburn medications include a class of drugs called proton-pump inhibitors, or PPIs, such as over-the-counter lansoprazole (Prevacid) or omeprazole (Prilosec). Long-term use of PPIs has been linked to reduced levels of vitamin B12, magnesium, and calcium, as well as an increased risk for hip fractures, pneumonia, and other life-threatening conditions. But Dr. Staller says the data supporting those risks aren't conclusive, and there's no evidence of risks from long-term use of H2 blockers.
Image: Luminola/Getty Images
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.